Loss of motor function in preclinical Alzheimer’s disease

References

• Bennett DA. Part II. Clinical diagnosis and course of Alzheimer’s disease. Dis. Mon.46(10), 666–687 (2000).
   PubMed Web of Science ®Google Scholar
• Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34(7), 939–944 (1984).
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Aggarwal NT et al. Decision rules guiding the clinical diagnosis of Alzheimer’s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology27(3), 169–176 (2006).
   PubMed Web of Science ®Google Scholar
• Arnold SE. Part III. Neuropathology of Alzheimer’s disease. Dis. Mon.46(10), 687–705 (2000).
   PubMedGoogle Scholar
• Mirra SS, Heyman A, McKeel D et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Neurology41(4), 479–479 (1991).
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol.82(4), 239–259 (1991).
   PubMed Web of Science ®Google Scholar
• Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol. Aging18(4 Suppl.), S1–S2 (1997).
   PubMed Web of Science ®Google Scholar
• Khachaturian ZS. Diagnosis of Alzheimer’s disease. Arch. Neurol.42(11), 1097–1105 (1985).
   PubMed Web of Science ®Google Scholar
• Rentz DM, Locascio JJ, Becker JA et al. Cognition, reserve, and amyloid deposition in normal aging. Ann. Neurol.67(3), 353–364 (2010).
   PubMed Web of Science ®Google Scholar
• Sperling RA, Laviolette PS, O’Keefe K et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron63(2), 178–188 (2009).
   PubMed Web of Science ®Google Scholar
• Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci.7(2), 331–356 (1968).
   PubMed Web of Science ®Google Scholar
• Katzman R, Terry R, Deteresa R et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol.23(2), 138–144 (1988).
   PubMed Web of Science ®Google Scholar
• Crystal HA, Dickson DW, Sliwinski MJ et al. Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol.34(4), 566–573 (1993).
   PubMed Web of Science ®Google Scholar
• Morris JC, Storandt M, Mckeel DW Jr. et al. Cerebral amyloid deposition and diffuse plaques in ‘normal’ aging: evidence for presymptomatic and very mild Alzheimer’s disease. Neurology46(3), 707–719 (1996).
   PubMed Web of Science ®Google Scholar
• Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, Mcintyre LM. Neuropathological and neuropsychological changes in ‘normal’ aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol.57(12), 1168–1174 (1998).
   PubMed Web of Science ®Google Scholar
• Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol.58(4), 376–388 (1999).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Grip strength and the risk of incident Alzheimer’s disease. Neuroepidemiology29(1–2), 66–73 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA. Olfactory impairment in presymptomatic Alzheimer’s disease. Ann. NY Acad. Sci.1170, 730–735 (2009).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Barnes LL, Mendes de Leon CF et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology59(3), 364–370 (2002).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology65(6), 892–897 (2005).
   PubMed Web of Science ®Google Scholar
• Hikosaka O, Nakamura K, Sakai K, Nakahara H. Central mechanisms of motor skill learning. Curr. Opin. Neurobiol.12(2), 217–222 (2002).
   PubMed Web of Science ®Google Scholar
• Burke RE. Some unresolved issues in motor unit research. Adv. Exp. Med. Biol.508, 171–178 (2002).
   PubMed Web of Science ®Google Scholar
• Burke RE (Ed.). Motor Units: Anatomy, Physiology and Functional Organization. American Physiological Society, DC, USA (1981).
   Google Scholar
• Jeannerod M, Arbib MA, Rizzolatti G, Sakata H. Grasping objects: the cortical mechanisms of visuomotor transformation. Trends Neurosci.18, 314–320 (1995).
   PubMed Web of Science ®Google Scholar
• Fogassi L, Luppino G. Motor functions of the parietal lobe. Curr. Opin. Neurobiology15(6), 626–631 (2005).
   PubMed Web of Science ®Google Scholar
• Fogassi L, Ferrari PF, Gesierich B, Rozzi S, Chersi F, Rizzolatti G. Parietal lobe: from action organization to intention understanding. Science308(5722), 662–667 (2005).
   PubMed Web of Science ®Google Scholar
• Rizzolatti G, Luppino G. The cortical motor system. Neuron31(6), 889–901 (2001).
   PubMed Web of Science ®Google Scholar
• Halsband U, Lange RK. Motor learning in man: a review of functional and clinical studies. J. Physiol. Paris99(4–6), 414–424 (2006).
   PubMed Web of Science ®Google Scholar
• Lehericy S, Bardinet E, Tremblay L et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb. Cortex16(2), 149–161 (2006).
   PubMed Web of Science ®Google Scholar
• Poppele R, Bosco G. Sophisticated spinal contributions to motor control. Trends Neurosci.26, 269–276 (2003).
   PubMed Web of Science ®Google Scholar
• Bizzi E, D’Avella A, Saltiel P, Tresch M. Modular organization of spinal motor systems. Neuroscientist8(5), 437–442 (2002).
   PubMed Web of Science ®Google Scholar
• Gosgnach S, Lanuza GM, Butt SJB et al. V1 spinal neurons regulate the speed of vertebrate locomotor outputs. Nature440(7081), 215–219 (2006).
   PubMed Web of Science ®Google Scholar
• Lanuza GM, Gosgnach S, Pierani A, Jessell TM, Goulding M. Genetic identification of spinal interneurons that coordinate left–right locomotor activity necessary for walking movements. Neuron42(3), 375–373 (2004).
   PubMed Web of Science ®Google Scholar
• Gordon IT, Whelan PJ. Deciphering the organization and modulation of spinal locomotor central pattern generators. J. Exp. Biol.209(11), 2007–2014 (2006).
   PubMed Web of Science ®Google Scholar
• Buford TW, Anton SD, Judge AR et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res. Rev.9(4), 369–383 (2010).
   PubMed Web of Science ®Google Scholar
• Buford TW, Cooke MB, Manini TM, Leeuwenburgh C, Willoughby DS. Effects of age and sedentary lifestyle on skeletal muscle NF-κB signaling in men. J. Gerontol. A Biol. Sci. Med. Sci.65A(5), 532–537 (2010).
   Google Scholar
• Zaehle T, Jordan K, Wüstenberg T, Baudewig J, Dechent P, Mast FW. The neural basis of the egocentric and allocentric spatial frame of reference. Brain Res.1137, 92–103 (2007).
   PubMed Web of Science ®Google Scholar
• Bakker M, De Lange FP, Helmich RC, Scheeringa R, Bloem BR, Toni I. Cerebral correlates of motor imagery of normal and precision gait. Neuroimage41(3), 998–1010 (2008).
   PubMed Web of Science ®Google Scholar
• Rosano C, Aizenstein HJ, Studenski S, Newman AB. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J. Gerontol. A Biol. Sci. Med. Sci.62(9), 1048–1055 (2007).
   PubMed Web of Science ®Google Scholar
• Rosano C, Brach J, Longstreth Jr WT, Newman AB. Quantitative measures of gait characteristics indicate prevalence of underlying subclinical structural brain abnormalities in high-functioning older adults. Neuroepidemiology26(1), 52–60 (2006).
   PubMed Web of Science ®Google Scholar
• Rosano C, Brach J, Studenski S, Longstreth WT Jr, Newman AB. Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology29(3–4), 193–200 (2007).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Wilson RS, Bienias JL, Bennett DA. Change in frailty and risk of death in older persons. Exp. Aging Res.35(1), 61–82 (2009).
   PubMed Web of Science ®Google Scholar
• Delmonico MJ, Harris TB, Lee J-S et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J. Am. Geriatr. Soc.55(5), 769–774 (2007).
   PubMed Web of Science ®Google Scholar
• Louis ED, Schupf N, Marder K, Tang MX. Functional correlates of mild parkinsonian signs in the community-dwelling elderly: poor balance and inability to ambulate independently. Mov. Disord.21(3), 411–416 (2006).
   PubMed Web of Science ®Google Scholar
• Onder G, Penninx BW, Ferrucci L, Fried LP, Guralnik JM, Pahor M. Measures of physical performance and risk for progressive and catastrophic disability: results from the Women’s Health and Aging Study. J. Gerontol. A Biol. Sci. Med. Sci.60(1), 74–79 (2005).
   PubMed Web of Science ®Google Scholar
• Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch. Neurol.62(2), 297–302 (2005).
   PubMedGoogle Scholar
• Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci.59(3), 255–263 (2004).
   PubMed Web of Science ®Google Scholar
• Louis ED, Bennett DA. Mild parkinsonian signs: an overview of an emerging concept. Mov. Disord.22(12), 1681–1688 (2007).
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol.147(8), 755–763 (1998).
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci.56(3), M146–M156 (2001).
   PubMed Web of Science ®Google Scholar
• Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology64(7), 1157–1161 (2005).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Change in motor function and risk of mortality in older persons. J. Am. Geriatr. Soc.55(1), 11–19 (2007).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Leurgans SE, Boyle PA, Schneider JA, Arnold SE, Bennett DA. Combinations of motor measures more strongly predict adverse health outcomes in old age: the Rush Memory and Aging Project, a community-based cohort study. BMC Med. (2011) (In press).
   PubMed Web of Science ®Google Scholar
• Chainay H, Louarn C, Humphreys GW. Ideational action impairments in Alzheimer’s disease. Brain Cogn.62(3), 198–205 (2006).
   PubMed Web of Science ®Google Scholar
• Derouesné C, Lagha-Pierucci S, Thibault S, Baudouin-Madec V, Lacomblez L. Apraxic disturbances in patients with mild to moderate Alzheimer’s disease. Neuropsychologia38(13), 1760–1769 (2000).
   PubMed Web of Science ®Google Scholar
• Della Sala S, Spinnler H, Venneri A. Walking difficulties in patients with Alzheimer’s disease might originate from gait apraxia. J. Neurol. Neurosurg. Psychiatry75(2), 196–201 (2004).
   PubMed Web of Science ®Google Scholar
• Hebert LE, Bienias JL, Mccann JJ, Scherr PA, Wilson RS, Evans DA. Upper and lower extremity motor performance and functional impairment in Alzheimer’s disease. Am. J. Alzheimers Dis. Other Demen.25(5), 425–431 (2010).
   PubMed Web of Science ®Google Scholar
• Agosta F, Rocca MA, Pagani E et al. Sensorimotor network rewiring in mild cognitive impairment and Alzheimer’s disease. Hum. Brain Mapp.31(4), 515–525 (2010).
   PubMed Web of Science ®Google Scholar
• Babiloni C, Frisoni GB, Vecchio F et al. Stability of clinical condition in mild cognitive impairment is related to cortical sources of α rhythms: an electroencephalographic study. Hum. Brain Mapp. DOI: 10.1002/hbm.21157 (2010) (Epub ahead of print).
   Google Scholar
• Jahng G-H, Xu S, Weiner M, Meyerhoff D, Park S, Schuff N. DTI studies in patients with Alzheimer’s disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients. Neuroradiology1–14–14 (2011).
   PubMed Web of Science ®Google Scholar
• Stump CS, Henriksen EJ, Wei Y, Sowers JR. The metabolic syndrome: role of skeletal muscle metabolism. Ann. Med.38(6), 389–402 (2006).
   PubMed Web of Science ®Google Scholar
• Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J. Am. Geriatr. Soc.56(1), 111–116 (2008).
   PubMed Web of Science ®Google Scholar
• Dahl A, Hassing LB, Fransson E et al. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J. Gerontol. A Biol. Sci. Med. Sci.65A(1), 57–62 (2010).
   Google Scholar
• Ogunniyi A, Gao S, Unverzagt FW et al. Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study. Int. Psychogeriatr.23(3), 387–394 (2010).
   PubMed Web of Science ®Google Scholar
• Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology71(14), 1057–1064 (2008).
   PubMed Web of Science ®Google Scholar
• Stewart R, Masaki K, Xue Q-L et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu–Asia Aging study. Arch. Neurol.62(1), 55–60 (2005).
   PubMedGoogle Scholar
• Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med.163(13), 1524–1528 (2003).
   PubMed Web of Science ®Google Scholar
• Verdijk LB, Snijders T, Beelen M et al. Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men. J. Am. Geriatr. Soc.58(11), 2069–2075 (2010).
   PubMed Web of Science ®Google Scholar
• Deschenes MR. Effects of aging on muscle fibre type and size. Sports Med.34(12), 809–824 (2004).
   PubMed Web of Science ®Google Scholar
• Hairi NN, Cumming RG, Naganathan V et al. Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the concord Health and Ageing in Men Project. J. Am. Geriatr. Soc.58(11), 2055–2062 (2010).
   PubMed Web of Science ®Google Scholar
• Gustafson D. Adiposity indices and dementia. Lancet Neurol.5(8), 713–720 (2006).
   PubMed Web of Science ®Google Scholar
• Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. Arch. Neurol.66(11), 1339–1344 (2009).
   PubMed Web of Science ®Google Scholar
• Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve25(1), 17–25 (2002).
   PubMed Web of Science ®Google Scholar
• Camicioli R, Howieson D, Oken B, Sexton G, Kaye J. Motor slowing precedes cognitive impairment in the oldest old. Neurology50(5), 1496–1498 (1998).
   PubMed Web of Science ®Google Scholar
• Buracchio T, Dodge HH, Howieson D, Wasserman D, Kaye J. The trajectory of gait speed preceding mild cognitive impairment. Arch. Neurol.67(8), 980–989 (2010).
   PubMed Web of Science ®Google Scholar
• Boyle PA, Wilson RS, Buchman AS et al. Lower extremity motor function and disability in mild cognitive impairment. Exp. Aging Res.33(3), 355–371 (2007).
   PubMed Web of Science ®Google Scholar
• Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch. Neurol.63(12), 1763–1769 (2006).
   PubMed Web of Science ®Google Scholar
• Watson NL, Rosano C, Boudreau RM et al. Executive function, memory, and gait Speed decline in well-functioning older adults. J. Gerontol. A Biol. Sci. Med. Sci.65A(10), 1093–1100 (2010).
   Google Scholar
• Wang L, Larson EB, Bowen JD, Van Belle G. Performance-based physical function and future dementia in older people. Arch. Intern. Med.166(10), 1115–1120 (2006).
   PubMed Web of Science ®Google Scholar
• Inzitari M, Newman AB, Yaffe K et al. Gait speed predicts decline in attention and psychomotor speed in older adults: the Health Aging and Body Composition Study. Neuroepidemiology29, 156–162 (2007).
   PubMed Web of Science ®Google Scholar
• Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J. Neurol. Sci.229–230, 89–93 (2005).
   PubMed Web of Science ®Google Scholar
• Ble A, Volpato S, Zuliani G et al. Executive function correlates with walking speed in older persons: the InCHIANTI study. J. Am. Geriatr. Soc.53(3), 410–415 (2005).
   PubMed Web of Science ®Google Scholar
• Soumare A, Tavernier B, Alperovitch A, Tzourio C, Elbaz A. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. J. Gerontol. A Biol. Sci. Med. Sci.1058–1065 (2009).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch. Neurol.60(4), 539–544 (2003).
   PubMedGoogle Scholar
• Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology43(11), 2184–2188 (1993).
   PubMed Web of Science ®Google Scholar
• Portet F, Scarmeas N, Cosentino S, Helzner EP, Stern Y. Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch. Neurol.66(9), 1120–1126 (2009).
   PubMedGoogle Scholar
• Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J. Am. Geriatr. Soc.52(4), 625–634 (2004).
   PubMed Web of Science ®Google Scholar
• Bandeen-Roche K, Xue Q-L, Ferrucci L et al. Phenotype of frailty: characterization in the women’s health and aging studies. J. Gerontol. A Biol. Sci. Med. Sci.61(3), 262–266 (2006).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, Tang Y, Bennett DA. Frailty is associated with incident Alzheimer’s disease and cognitive decline in the elderly. Psychosom. Med.69(5), 483–489 (2007).
   PubMed Web of Science ®Google Scholar
• Boyle PA, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J. Am. Geriatr. Soc.58(2), 248–255 (2010).
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Kaley G, De Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci.65A(10), 1028–1041 (2010).
   Google Scholar
• Dilger RN, Johnson RW. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol.84(4), 932–939 (2008).
   PubMed Web of Science ®Google Scholar
• Kapogiannis D, Mattson MP. Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer’s disease. Lancet Neurol.10(2), 187–198 (2011).
   PubMed Web of Science ®Google Scholar
• Sultana R, Perluigi M, Butterfield D. Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Aβ in pathogenesis. Acta Neuropathologica118(1), 131–150 (2009).
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol.61(3), 378–384 (2004).
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE. Amyloid mediates the association of apolipoprotein E ε4 allele to cognitive function in older people. J. Neurol. Neurosurg. Psychiatry76(9), 1194–1199 (2005).
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y. Inaugural article: apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc. Natl Acad. Sci.103(15), 5644–5651 (2006).
   PubMed Web of Science ®Google Scholar
• Houlden H, Greenwood R. Apolipoprotein E4 and traumatic brain injury. J. Neurol. Neurosurg. Psychiatry77(10), 1106–1107 (2006).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Schneider JA, Barnes LL et al. The apolipoprotein E ε4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol.59(7), 1154–1160 (2002).
   PubMedGoogle Scholar
• Sudlow C, Martinez Gonzalez NA, Kim J, Clark C. Does Apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage?: systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke37(2), 364–370 (2006).
   PubMed Web of Science ®Google Scholar
• Burt TD, Agan BK, Marconi VC et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression. Proc. Natl Acad. Sci.105(25), 8718–8723 (2008).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, Beck T, Kelly JF, Bennett DA. Apolipoprotein E ε4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis. Assoc. Disord.23, 63–69 (2009).
   PubMed Web of Science ®Google Scholar
• Jun G, Naj AC, Beecham GW et al. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch. Neurol.67(12), 1473–1484 (2010).
   PubMedGoogle Scholar
• Seshadri S, Fitzpatrick AL, Ikram MA et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA303(18), 1832–1840 (2010).
   PubMed Web of Science ®Google Scholar
• Claeys KG, Maisonobe T, Böhm J et al. Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation. Neurology74(6), 519–521 (2010).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Arnold SE, Tang Y, Bennett DA. Odor identification and decline in different cognitive domains in old age. Neuroepidemiology26(2), 61–67 (2006).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mild cognitive impairment in older age. Arch. Gen. Psychiatry64(7), 802–808 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA. Lewy bodies and olfactory dysfunction in old age. Chem. Senses DOI: 10.1093/chemse/bjq139 (2011) (Epub ahead of print).
   Google Scholar
• Wilson RS, Arnold SE, Buchman AS, Tang Y, Bennett DA. Odor identification and progression of parkinsonian signs in older persons. Exp. Aging Res.34(3), 173–187 (2008).
   PubMed Web of Science ®Google Scholar
• Schubert CR, Carmichael LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J. Am. Geriatr. Soc.56(8), 1517–1521 (2008).
   PubMed Web of Science ®Google Scholar
• Olofsson JK, Ronnlund M, Nordin S, Nyberg L, Nilsson LG, Larsson M. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-ε4. Behav. Genet.39(5), 496–503 (2009).
   PubMed Web of Science ®Google Scholar
• Schrijvers EMC, Witteman JCM, Sijbrands EJG, Hofman A, Koudstaal PJ, Breteler MMB. Insulin metabolism and the risk of Alzheimer disease. Neurology75(22), 1982–1987 (2010).
   PubMed Web of Science ®Google Scholar
• Rocca WA, Petersen RC, Knopman DS et al. Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Demen.7(1), 80–93 (2011).
   PubMed Web of Science ®Google Scholar
• Hoffman LB, Schmeidler J, Lesser GT et al. Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology72(20), 1720–1726 (2009).
   PubMed Web of Science ®Google Scholar
• Beeri MS, Ravona-Springer R, Silverman JM, Haroutunian V. The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin. Neurosci.11(2), 201–212 (2009).
   PubMedGoogle Scholar
• Arvanitakis Z, Bennett DA, Wilson RS, Barnes LL. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis. Assoc. Disord.24(1), 37–42 (2009).
   Web of Science ®Google Scholar
• Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol.61(5), 661–666 (2004).
   PubMed Web of Science ®Google Scholar
• Arvanitakis Z, Wilson RS, Li Y, Aggarwal NT, Bennett DA. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care29(3), 560–565 (2006).
   PubMed Web of Science ®Google Scholar
• Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. Hypertension and lower walking speed in the elderly: the Three-City study. J. Hypertension28(7), 1506–1514. (2010).
   PubMed Web of Science ®Google Scholar
• Sorond FA, Galica A, Serrador JM et al. Cerebrovascular hemodynamics, gait, and falls in an elderly population. Neurology74(20), 1627–1633 (2010).
   PubMed Web of Science ®Google Scholar
• Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA. Diabetes and parkinsonian signs in older persons. Alzheimer Dis. Assoc. Disord.21(2), 144–149 (2007).
   PubMed Web of Science ®Google Scholar
• Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology63(6), 996–1001 (2004).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, Leurgans S, Shah RC, Bennett DA. Respiratory muscle strength predicts decline in mobility in older persons. Neuroepidemiology31(3), 174–180 (2008).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Leurgans SE, Evans DA, Bennett DA. Pulmonary function, muscle strength and mobility disability in community-dwelling elders. Proc. Am. Thorac. Soc.6, 581–587 (2009).
   PubMedGoogle Scholar
• Warburton DE, Nicol CW, Bredin SS. Health benefits of physical activity: the evidence. CMAJ174(6), 801–809 (2006).
   PubMed Web of Science ®Google Scholar
• Larson EB. Physical activity for older adults at risk for Alzheimer disease. JAMA300(9), 1077–1079 (2008).
   PubMed Web of Science ®Google Scholar
• Barak Y, Aizenberg D. Is dementia preventable? Focus on Alzheimer’s disease. Expert Rev. Neurother.10(11), 1689–1698 (2010).
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Luchsinger JA, Schupf N et al. Physical activity, diet, and risk of Alzheimer disease. JAMA302(6), 627–637 (2009).
   PubMed Web of Science ®Google Scholar
• Lautenschlager NT, Cox KL, Flicker L et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA300(9), 1027–1037 (2008).
   PubMed Web of Science ®Google Scholar
• Liu-Ambrose T, Nagamatsu LS, Graf P, Beattie BL, Ashe MC, Handy TC. Resistance training and executive functions: a 12-month randomized controlled trial. Arch. Intern. Med.170(2), 170–178 (2010).
   PubMed Web of Science ®Google Scholar
• Dechamps A, Diolez P, Thiaudiere E et al. Effects of exercise programs to prevent decline in health-related quality of life in highly deconditioned institutionalized elderly persons: a randomized controlled trial. Arch. Int. Med.170(2), 162–169 (2010).
   PubMed Web of Science ®Google Scholar
• Etgen T, Sander D, Huntgeburth U, Poppert H, Forstl H, Bickel H. Physical activity and incident cognitive impairment in elderly persons: the INVADE Study. Arch. Int. Med.170(2), 186–193 (2010).
   PubMedGoogle Scholar
• Evans DA, Bienias JL. Alcohol consumption and cognition. N. Engl. J. Med.352(3), 289–290 (2005).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, Bienias JL, Bennett DA. Physical activity and motor decline in older persons. Muscle Nerve35, 354–362 (2007).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Wilson RS, Fleischman DA, Leurgans S, Bennett DA. Association between late-life social activity and motor decline in older adults. Arch. Int. Med.169(12), 1139–1146 (2009).
   PubMed Web of Science ®Google Scholar
• Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol.3(6), 343–353 (2004).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Arnold SE, Schneider JA, Li Y, Bennett DA. Chronic distress, age-related neuropathology, and late-life dementia. Psychosom. Med.69(1), 47–53 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Evans DA, Bienias JL, Mendes de Leon CF, Schneider JA, Bennett DA. Proneness to psychological distress and risk of Alzheimer’s disease. Neurology61(11), 1479–1485 (2003).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Krueger KR, Arnold SE et al. Loneliness and risk of Alzheimer disease. Arch. Gen. Psychiatry64(2), 234–240 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson RS, Schneider JA, Boyle PA, Arnold SE, Tang Y, Bennett DA. Chronic distress and incidence of mild cognitive impairment. Neurology68(24), 2085–2092 (2007).
   PubMed Web of Science ®Google Scholar
• Buchman A, Boyle P, Wilson R et al. Loneliness and the rate of motor decline in old age: the Rush Memory and Aging Project, a community-based cohort study. BMC Geriatrics10(1), 77 (2010).
   PubMed Web of Science ®Google Scholar
• Rhodes RE, Smith NEI. Personality correlates of physical activity: a review and meta-analysis. Br. J. Sports Med.40(12), 958–965 (2006).
   PubMed Web of Science ®Google Scholar
• Tolea MI, Costa PT, Terracciano A et al. Sex-specific correlates of walking speed in a wide age-ranged population. J. Gerontol. B Psycholog. Sci. Soc. Sci.65B(2), 174–184 (2010).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Boyle PA, Leurgans SE, Barnes LL, Bennett DA. Cognitive function is associated with the development of mobility impairments in community-dwelling elders. Am. J. Geriatr. Psych. DOI: 10.1097/JGP.1090b1013e3181ef1097a1092e (2011) (Epub ahead of print).
   Google Scholar
• Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol.66(2), 200–208 (2009).
   PubMed Web of Science ®Google Scholar
• Bennett DA, Schneider JA, Arvanitakis Z et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology66(12), 1837–1844 (2006).
   PubMed Web of Science ®Google Scholar
• Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ339, b2680 (2009).
   PubMedGoogle Scholar
• Salajegheh M, Pinkus JL, Nazareno R, Amato AA, Parker KC, Greenberg SA. Nature of ‘Tau’ immunoreactivity in normal myonuclei and inclusion body myositis. Muscle Nerve40(4), 520–528 (2009).
   PubMed Web of Science ®Google Scholar
• Cisek P, Kalaska JF. Neural mechanisms for interacting with a world full of action choices. Ann. Rev. Neurosci.33(1), 269–298 (2010).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Schneider JA, Wilson RS, Bienias JL, Bennett DA. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology67, 1949–1954 (2006).
   PubMed Web of Science ®Google Scholar
• Buchman AS, Schneider JA, Leurgans S, Bennett DA. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology71(7), 499–504 (2008).
   PubMed Web of Science ®Google Scholar
• Schneider JA, Li JL, Li Y, Wilson RS, Kordower JH, Bennett DA. Substantia nigra tangles are related to gait impairment in older persons. Ann. Neurol.59(1), 166–173 (2006).
   PubMed Web of Science ®Google Scholar
• Gearing M, Levey AI, Mirra SS. Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. J. Neuropathol. Exp. Neurol.56(12), 1363–1370 (1997).
   PubMed Web of Science ®Google Scholar
• Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS. Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer Dis. Assoc. Disord.13(4), 226–231 (1999).
   PubMed Web of Science ®Google Scholar
• Horoupian DS, Wasserstein PH. Alzheimer’s disease pathology in motor cortex in dementia with Lewy bodies clinically mimicking corticobasal degeneration. Acta Neuropathol. (Berl.)98(3), 317–322 (1999).
   PubMed Web of Science ®Google Scholar
• Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology64(8), 1397–1403 (2005).
   PubMed Web of Science ®Google Scholar
• Suva D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Miklossy J. Primary motor cortex involvement in Alzheimer disease. J. Neuropathol. Exp. Neurol.58(11), 1125–1134 (1999).
   PubMed Web of Science ®Google Scholar
• Bennett DA, Wilson RS, Schneider JA et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology60(12), 1909–1915 (2003).
   PubMed Web of Science ®Google Scholar
• Boyle PA, Wilson RS, Schneider JA, Bienias JL, Bennett DA. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems. Neurology70(17), 1534–1542 (2008).
   PubMed Web of Science ®Google Scholar
• Rose G. The Strategy of Preventive Medicine. Oxford University Press, Oxford, UK (1992).
   Google Scholar
• Nithianantharajah J, Hannan AJ. The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders. Prog. Neurobiol.89(4), 369–382 (2009).
   PubMed Web of Science ®Google Scholar